D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Despite the recent rally, Vista is still quoted with a EV/EBITDA FWD of only 3.93x, a P/E FWD of 10.25x, and an FCF yield ...

The release for Magic: the Gathering's latest set, Edge of Eternities, is right around the corner. Like most sets, this ...

The S&P 500 climbed 0.61% on Wednesday (July 9), driven by gains in tech stocks as Nvidia hit a historic milestone and ...

Discover the real science behind Mitolyn, the metabolic complaints it’s silencing, verified 90-day results, and why thousands ...

The European Union cannot practically declare its independence from Nvidia GPUs any more than any other nation can at this ...

The prospect that some managed service providers could fall foul of the needs of the insurance industry is a concern raised by Canalys ...

The term “real time” is causing CIOs to rethink their data strategy and find ways to more seamlessly unify not just data, but ...

A group of CEOs is urging the European Union to accelerate hydrogen mobility development or risk losing a strategic economic and security advantage. But another prominent group argues that hydrogen is ...

As tensions rise in the Caspian region, Kazakhstan’s nonproliferation legacy and multi-vector diplomacy uniquely position it to mediate with Iran and maintain regional stability amid nuclear and ...